Latest news
Loading news…
Abcam helps researches with breakthroughs in areas such as cancer, neurological disorders, infectious diseases, and metabolic disorders.
Abcam was acquired by Danaher in 2023 for $6B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
8
Investments
1
Monthly Visits
Available in Pro Contacts
919
Patents
42
6 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 96
- Mobile apps
- 2
- Downloads (30d)
- 21
- Active products
- 30
- Patents granted
- 42
- Trademarks
- 6
- Top patent class
- Organic Chemistry
- IT spend
- $39M
Investor Activity
- Investments
- 1
- Portfolio orgs
- 1
Company Info
- Org types
- company, investor
- HQ
- Cambridge, Cambridgeshire, United Kingdom
Signals & Scores
- Trend (7d)
- 0
- Trend (30d)
- -0.3
- Trend (90d)
- -0.1
Investments by Abcam
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Abcam
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Abcam
SVP, Supply Chain & Manufacturing
Chief Financial Officer
Vice President Research and Innovation
RPA Analyst
Director of Computational R&D
Director Of Business Development
919
professional contacts at Abcam
Contact execs at Abcam →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Abcam
Loading news…
FAQs about Abcam
People who checked this page also checked these
Sectors Abcam invests & acquires in
Browse the full Acquirezy directory.